Diabetes Technology & Therapeutics

Editor-in-Chief: Satish K. Garg, MD

ISSN: 1520-9156 | Online ISSN: 1557-8593 | Published Monthly | Current Volume: 23

Impact Factor: 6.118 2020 Journal Citation Reports (Clarivate, 2021)

CiteScore™: 9.0

The only peer-reviewed journal covering all aspects of diagnosing and managing diabetes with cutting-edge devices, drugs, drug delivery systems, and software.

Search Subscribe/Renew Recommend This Title Sign Up for TOC Alerts Submit a Paper Share with a Colleague

News Releases

Tuesday, September 21, 2021

Continuous Glucose Monitoring for Remote Diabetes Management during the COVID-19 Pandemic

Thursday, March 4, 2021

COVID-19 Antibodies: Prevalence in Individuals with Diabetes vs General Population

Friday, February 19, 2021

Standardizing Reporting for Patients Using Connected Insulin Pens and Continuous Glucose Monitoring

Monday, November 30, 2020

“Artificial Pancreas Dashboard” to Standardize Hybrid Closed-Loop Reporting

Friday, May 15, 2020

Using Telehealth to Transition Diabetes Inpatients to Virtual Care During COVID-19

Monday, May 11, 2020

Telehealth During COVID-19 May Lead to Better Outcomes for Diabetes Patients

Tuesday, April 21, 2020

Tele-diabetes to Manage New-Onset Diabetes During COVID-19 Pandemic

Friday, January 25, 2019

Harvard Researchers Report Positive Trial Results With Artificial Pancreas Smartphone App

Tuesday, January 22, 2019

Fewer Than Half of Adults and Youth With Type 1 Diabetes In the U.S. Achieve Treatment Goals

Wednesday, January 9, 2019

New Data Emphasize Importance of Avoiding Hypoglycemic Glucose Levels in Type 1 Diabetes

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.